Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.

ABSTRACT:

Background

Academic physicians, such as those affiliated with National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, may have different practice patterns regarding the use of high-cost cancer drugs than nonacademic physicians.

Materials and methods

For this cohort study, we linked cancer registry, administrative, and demographic data for patients with newly diagnosed cancer in North Carolina from 2004 to 2011. We selected cancer types with multiple U.S. Food and Drug Administration-approved, National Comprehensive Cancer Network-recommended treatment options and large differences in reimbursement between higher-priced and lower-priced options (stage IV colorectal, stage IV lung, and stage II-IV head-and-neck cancers). We assessed whether provider's practice

SUBMITTER: Mitchell AP 

PROVIDER: S-EPMC6964140 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature